BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10231467)

  • 1. Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
    Cueto-Manzano AM; Konel S; Hutchison AJ; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R
    Kidney Int; 1999 May; 55(5):2021-9. PubMed ID: 10231467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
    Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pamidronate therapy as prevention of bone loss following renal transplantation.
    Fan SL; Almond MK; Ball E; Evans K; Cunningham J
    Kidney Int; 2000 Feb; 57(2):684-90. PubMed ID: 10652047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sex hormone status with the bone loss of renal transplant patients.
    Cueto-Manzano AM; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Nephrol Dial Transplant; 2001 Jun; 16(6):1245-50. PubMed ID: 11390727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
    Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
    Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
    Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in the long term after liver transplantation.
    Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
    Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [value of bone densitometry in pediatric renal transplantation].
    Melgosa Hijosa M; Romero de Paz MD; García Meseguer MC; Alonso Melgar A; Coya J; Navarro M
    An Esp Pediatr; 1997 Oct; 47(4):373-7. PubMed ID: 9499304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional analysis of renal transplantation osteoporosis.
    Parker CR; Freemont AJ; Blackwell PJ; Grainge MJ; Hosking DJ
    J Bone Miner Res; 1999 Nov; 14(11):1943-51. PubMed ID: 10571695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.
    Rolla D; Ballanti P; Marsano L; Bianchi G; Messa P; Paoletti E; Cannella G
    Transplantation; 2006 Mar; 81(6):915-21. PubMed ID: 16570017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and causes of low bone density and fractures in kidney transplant patients.
    Patel S; Kwan JT; McCloskey E; McGee G; Thomas G; Johnson D; Wills R; Ogunremi L; Barron J
    J Bone Miner Res; 2001 Oct; 16(10):1863-70. PubMed ID: 11585351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of regional bone mineral density in the first 12 months following renal transplantation.
    Almond MK; Kwan JT; Evans K; Cunningham J
    Nephron; 1994; 66(1):52-7. PubMed ID: 8107953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.
    Abdelhadi M; Nordenström J
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.
    Lehmann G; Ott U; Stein G; Steiner T; Wolf G
    Transplant Proc; 2007 Dec; 39(10):3153-8. PubMed ID: 18089342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
    Duan Y; De Luca V; Seeman E
    J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation.
    Fan SL; Kumar S; Cunningham J
    Kidney Int; 2003 Jun; 63(6):2275-9. PubMed ID: 12753318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.